Plasma levels of soluble Fas during treatment of chronic hepatitis C patients with interferon alpha

J Hepatol. 1999 Sep;31(3):575. doi: 10.1016/s0168-8278(99)80056-7.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / immunology
  • Humans
  • Interferon-alpha / therapeutic use*
  • Ligands
  • Solubility
  • fas Receptor / blood*

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Ligands
  • fas Receptor